Document is current
Any future updates will be listed below
-
Authors
Mannar, Dhiraj
Saville, James W.
Sun, Zehua
Zhu, Xing
Marti, Michelle M.
Srivastava, Shanti S. https://orcid.org/0000-0002-4208-6127
Berezuk, Alison M. https://orcid.org/0000-0001-8512-0180
Zhou, Steven
Tuttle, Katharine S.
Sobolewski, Michele D.
Kim, Andrew
Treat, Benjamin R.
Da Silva Castanha, Priscila Mayrelle
Jacobs, Jana L.
Barratt-Boyes, Simon M.
Mellors, John W.
Dimitrov, Dimiter S. https://orcid.org/0000-0002-2258-1024
Li, Wei
Subramaniam, Sriram https://orcid.org/0000-0003-4231-4115
-
Funding
Funding for this research was provided by:
Canada Excellence Research Chairs, Government of Canada (F18-03211)
- License Information
-
More Information
Article History
Received: 7 December 2021
Accepted: 21 July 2022
First Online: 18 August 2022
Competing interests
: Z.S., W.L., J.W.M., and D.S.D. are coinventors of a patent, filed by the University of Pittsburgh, related to ab6, ab1, and ab8 that were assessed in this manuscript. S.S. is the Founder and CEO of Gandeeva Therapeutics Inc. The remaining authors declare no competing interests.
